Arcturus Therapeutics Announces First Quarter 2021 Company Overview and Financial Results and Provides New Clinical Data

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Arcturus Therapeutics Announces First Quarter 2021 Company Overview and Financial Results and Provides New Clinical Data

Arcturus Therapeutics (ARCT) Misses Q1 EPS by 90c

May 10, 2021 4:33 PM EDT

Arcturus Therapeutics (NASDAQ: ARCT) reported Q1 EPS of ($2.15), $0.90 worse than the analyst estimate of ($1.25). Revenue for the quarter came in at $2.13 million versus the consensus estimate of $2.54 million.

For earnings history and earnings-related data on Arcturus Therapeutics (ARCT) click here.

... More